We propose that strontium treatment of uncommitted cells triggers VEGF secretion and RhoA/Rac1 activation, leading to OB promotion and AD restriction to finally help bone cells to resist against microgravity conditions. This evidence concerns the gene RHOA and Alzheimer disease.